Attached files
| file | filename |
|---|---|
| 10-K - 10-K - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-10k_20201231.htm |
| EX-32.1 - EX-32.1 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex321_7.htm |
| EX-31.2 - EX-31.2 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex312_8.htm |
| EX-31.1 - EX-31.1 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex311_9.htm |
| EX-21.1 - EX-21.1 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex211_6.htm |
| EX-10.24 - EX-10.24 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex1024_291.htm |
| EX-10.3 - EX-10.3 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex103_292.htm |
| EX-4.7 - EX-4.7 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex47_10.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Helius Medical Technologies, Inc.
Newtown, Pennsylvania
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-236101), Form S-1 (No. 333-250974 and 333-248824) and Form S-8 (No. 333-204155, 333-218095 and 333-229724) of Helius Medical Technologies, Inc., of our report dated March 10, 2021, relating to the consolidated financial statements of Helius Medical Technologies, Inc., which appears in this Annual Report on Form 10-K for the year ended December 31, 2020. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
Philadelphia, Pennsylvania
March 10, 2021